Hypereosinophilic Syndrome Clinical Trials in Salt Lake City, Utah
2 recruitingSalt Lake City, Utah
Showing 1–2 of 2 trials
Recruiting
Phase 2
Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders
Blasts More Than 5 Percent of Bone Marrow Nucleated CellsChronic Eosinophilic Leukemia-not Otherwise SpecifiedBCR-JAK2 Fusion Protein Expression+9 more
William Shomali10 enrolled4 locationsNCT03801434
Recruiting
Phase 3
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
Hypereosinophilic Syndrome
GlaxoSmithKline123 enrolled91 locationsNCT05334368